+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Phenotypic alterations of small cell lung carcinoma induced by different levels of wild-type p53 expression



Phenotypic alterations of small cell lung carcinoma induced by different levels of wild-type p53 expression



Cell Death and Differentiation 5(2): 148-155



p53 induces both growth arrest and apoptosis in cancer cells. To clarify whether the level of p53 expression determines the response of small cell lung carcinoma (SCLC) cells, we assessed the effect of various p53 levels on a p53-null SCLC cell line, N417, using a tetracycline (Tc)-regulated inducible p53 expression system. Apoptosis was induced in SCLC cells with high p53 expression. Although low levels of p53 induced G1 arrest accompanied by p21 expression, cells with G1 arrest seemed to undergo apoptosis after further cultivation. Expression of exogenous p21 induced G1 arrest but not apoptosis in SCLC cells, suggesting that p53-mediated G1 arrest was induced through p21 expression. Moreover, high level of p53 expression down-regulated Bcl-2 expression in SCLC cells, while Bax was consistently expressed irrespective to the level of p53 expression. These results suggest that p53-mediated apoptosis and G1 arrest depend on level of p53 expression in SCLC cells and that the relative dominancy of Bax to Bcl-2 is involved in the induction of apoptosis by high level of p53 expression.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 046973780

Download citation: RISBibTeXText

PMID: 10200459


Related references

Induction of apoptosis but not G1 arrest by expression of the wild-type p53 gene in small cell lung carcinoma. Cell Growth & Differentiation 7(7): 879-886, 1996

Adenoviral-mediated wild-type p16 gene expression radiosensitizes non-small cell lung cancer cells that express wild type p53. Proceedings of the American Association for Cancer Research Annual Meeting (41): 604, 2000

Differential expression of cell adhesion molecules in phenotypic variants of the small cell lung carcinoma cell line NCI-H69. In Vitro Cellular & Developmental Biology. Animal 34(9): 677-678, 1998

Changes in expression of neural cell adhesion molecule and desmoplakin associated with phenotypic transitions in cloned cell lines from a non-small cell lung carcinoma. International Journal Of Oncology. 6(3): 617-623, 1995

Expression of wild type p53, mutant p53, bcl-2 and apoptosis during lung carcinogenesis and in non-small cell lung cancer. Proceedings of the American Association for Cancer Research Annual Meeting 37: 26, 1996

Phenotypic changes induced in small cell lung carcinoma cells by overexpression of myc and ras oncogenes. Molecular & Cellular Differentiation 2(4): 373-398, 1994

Wild-type p53 overexpression and its correlation with MDM2 and p14ARF alterations: an alternative pathway to non-small-cell lung cancer. Journal of Clinical Oncology 23(1): 154-164, 2005

UCN-01 synergizes with cisplatin in non-small cell lung carcinoma cell lines with wild-type and mutant RB and p53. Journal of Investigative Medicine 46(1): 126A, 1998

Histological specificity of alterations and expression of KIT and KITLG in non-small cell lung carcinoma. Genes Chromosomes and Cancer 52(11): 1088-1096, 2013

Adenovirus-mediated wild-type p53 gene expression radiosensitizes non-small cell lung cancer cells but not normal lung fibroblasts. International Journal of Radiation Biology 77(2): 185-194, 2001

Differences in gene expression levels between early and later stages of human lung development are opposite to those between normal lung tissue and non-small lung cell carcinoma. Lung Cancer 62(1): 23-34, 2008

Alterations of expression of Rb, p16(INK4A) and cyclin D1 in non-small cell lung carcinoma and their clinical significance. Journal of Pathology 188(4): 351-360, 1999

Bcl-2 oncoprotein expression is increased especially in the portion of small cell carcinoma within the combined type of small cell lung cancer. Tumour Biology 17(6): 341-344, 1996

Expression of wild type wt p53 and mutant m p53 p53 oncogene in non small cell lung cancer. American Review of Respiratory Disease 145(4 Part 2): A424, 1992